Evidence map›Paper›PMID 34306191›Full record

ReviewExperimental and therapeutic medicine2021

Comparative effects of capsaicin in chronic obstructive pulmonary disease and asthma (Review).

Mihai-Daniel Dumitrache, Ana Stefania Jieanu, Cristian Scheau, Ioana Anca Badarau, George Denis Alexandru Popescu, Ana Caruntu, Daniel Octavian Costache, Raluca Simona Costache, Carolina Constantin, Monica Neagu and 1 more

Open access · diamondAbstract readReview
In one paragraph

Review in Experimental and therapeutic medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Capsaicin: Emerging Pharmacological and Therapeutic Insights.Current issues in molecular biology · 2024
    Review
  6. Article
  7. Role of Cannabinoids in Oral Cancer.International journal of molecular sciences · 2024
    Review
  8. Kaempferol: A Review of Current Evidence of Its Antiviral Potential.International journal of molecular sciences · 2023
    Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Mihai-Daniel DumitracheDepartment of Pneumology IV, 'Marius Nasta' Institute of Pneumophtysiology, 050159 Bucharest, Romania.
Ana Stefania JieanuDepartment of Physiology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Cristian ScheauDepartment of Physiology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Ioana Anca BadarauDepartment of Physiology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
George Denis Alexandru PopescuDepartment of Medical Oncology II, 'Prof. Dr. Alexandru Trestioreanu' Institute of Oncology, 022328 Bucharest, Romania.
Ana CaruntuDepartment of Oral and Maxillofacial Surgery, 'Dr. Carol Davila' Central Military Emergency Hospital, 010825 Bucharest, Romania.
Daniel Octavian CostacheDepartment of Dermatology, 'Dr. Carol Davila' Central Military Emergency Hospital, 010825 Bucharest, Romania.
Raluca Simona CostacheDepartment of Gastroenterology, Gastroenterology and Internal Medicine Clinic, 'Dr. Carol Davila' Central Military Emergency Hospital, 010825 Bucharest, Romania.
Carolina ConstantinDepartment of Immunology, 'Victor Babes' National Institute of Pathology, 050096 Bucharest, Romania.
Monica NeaguDepartment of Immunology, 'Victor Babes' National Institute of Pathology, 050096 Bucharest, Romania.
Constantin CaruntuDepartment of Physiology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Carol Davila University of Medicine and Pharmacy · ROInstitutul National Victor Babes · ROClinical Emergency Hospital Bucharest · ROInstitutul de Pneumoftiziologie "Marius Nasta" · ROInstitutul Oncologic Bucuresti · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) and asthma are chronic respiratory diseases with high prevalence and mortality that significantly alter the quality of life in affected patients. While the cellular and molecular mechanisms engaged in the development and evolution of these two conditions are different, COPD and asthma share a wide array of symptoms and clinical signs that may impede differential diagnosis. However, the distinct signaling pathways regulating cough and airway hyperresponsiveness employ the interaction of different cells, molecules, and receptors. Transient receptor potential cation channel subfamily V member 1 (TRPV1) plays a major role in cough and airway inflammation. Consequently, its agonist, capsaicin, is of substantial interest in exploring the cellular effects and regulatory pathways that mediate these respiratory conditions. Increasingly more studies emphasize the use of capsaicin for the inhalation cough challenge, yet the involvement of TRPV1 in cough, bronchoconstriction, and the initiation of inflammation has not been entirely revealed. This review outlines a comparative perspective on the effects of capsaicin and its receptor in the pathophysiology of COPD and asthma, underlying the complex entanglement of molecular signals that bridge the alteration of cellular function with the multitude of clinical effects.

Indexed as

asthmacapsaicinchronic obstructive pulmonary diseasecoughinflammationsignaling pathwaystransient receptor potential cation channel subfamily V member 1

Identifiers

PMID34306191
PMCPMC8280727
OpenAlexW3176676806

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.